1 | Hematology Grants Workshop-2000. (Todd RF 3rd, Miller DM, Silverstein RL) Hematology Am Soc Hematol Educ Program 2000:424-437 |
1 | Hematology grants workshop-2001. (Todd RF 3rd, Miller DM, Silverstein RL) Hematology Am Soc Hematol Educ Program 2001:507-21 2 Citations |
1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology) Blood 2002 Oct 01;100(7):2303-20 204 Citations |
1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology) J Clin Oncol 2002 Oct 01;20(19):4083-107 402 Citations |
1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE) Blood 2008 Jan 01;111(1):25-41 144 Citations |
1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2008 Jan 01;26(1):132-49 260 Citations |
1 | Molecular Therapeutics in Hematology: Gene Therapy (Medin JA) Molecular Hematology: Third Edition 10 March 2010:318-335 |
1 | American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee) Blood 2010 Nov 18;116(20):4045-59 180 Citations |
1 | American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2010 Nov 20;28(33):4996-5010 230 Citations |
1 | American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S) J Oncol Pract 2010 Nov;6(6):317-20 38 Citations |
1 | Integration of Electronic Patient-Reported Outcomes (ePROs) into pediatric clinic settings across hematology/oncology/bone marrow transplant (Myrvik MP, Beverung LM, Panepinto JA, Igler EC, Englebert N, Bingen KM) Clinical Practice in Pediatric Psychology 2014;2(1):39-49 11 Citations |
1 | Integration of electronic patient-reported outcomes into pediatric clinic settings across hematology/oncology/bone marrow transplant. (Myrvik, M., Beverung, L., Panepinto, J., Igler, E., Englebert, N., & BINGEN, K.) Clinical Practice in Pediatric Psychology Burgoyne, M.J., *BINGEN, K., Leuck, J., Dasgupta, M., Ryan, P., & Hoffmann, R.G. (2015, June). Cancer-related distress in young adults compared to middle-aged and senior adults. Journal of Adolescent and Young Adult Oncology, 4(2), 56-63. |
1 | NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology. (Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A) J Clin Apher 2016 Feb;31(1):38-47 6 Citations |
1 | Hematology and oncology disorders: Methemoglobinemia (Schindler CA) Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner 10 August 2015 |
1 | Hematology and oncology disorders: Aplastic anemia (Schindler CA) Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner 10 August 2015 |
1 | Hematology and oncology disorders: Diamond-blackfan anemia (diamond-blackfan anemia) (Schindler CA) Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner 10 August 2015 |
1 | Hematology and oncology disorders: Anemia: Acute (Schindler CA) Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner 10 August 2015 |
1 | Trends in End-of-Life Care in Pediatric Hematology, Oncology, and Stem Cell Transplant Patients. (Brock KE, Steineck A, Twist CJ) Pediatr Blood Cancer 2016 Mar;63(3):516-22 54 Citations |
1 | Women leaders in hematology: Inspirations & insights. (Quon D, Chitlur M, Rajpurkar M, Simpson M, O'Brien S, Flood V, Hsieh L, Acharya S, Kruse-Jarres R, Sood S, Maahs J) Am J Hematol 2016 Apr;91 Suppl 1:S6-S34 |
1 | Response: A Call for Psychosocial and Palliative Care Training Standards for Pediatric Hematology-Oncology Physicians, A Reply To: Communication, Documentation, and Training Standards in Pediatric Psychosocial Oncology. (Patenaude AF, Pelletier W, Bingen K) Pediatr Blood Cancer 2016 Jul;63(7):1315 |
1 | Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology. (Hicks LK, Rajasekhar A, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Sarode R, Wood WA) Am J Hematol 2016 Aug;91(8):787-92 8 Citations |
1 | A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways (Warsame R., Hubbard J., Thompson C.A., Croghan K., Tan A., Fruth B., Perez Botero J., Pachman D., Lafky V., Dispenzieri A., Sloan J) Journal of Clinical Pathways |
1 | Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. (Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW) Arch Pathol Lab Med 2017 Oct;141(10):1342-1393 76 Citations |
1 | Chapter: Hematology (J A Rivas, C Barriteau, S M Badawy) Blueprints Pediatrics |
1 | Molecular therapeutics in hematology: Gene therapy (McKillop WM, Medin JA) Molecular Hematology 1 January 2019:319-338 |
1 | ECMO Use in the Pediatric Immunocompromised Hematology/Oncology Patient (Niebler RA, Lehmann LE) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide 1 January 2019:275-290 |
1 | Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide (Duncan CN, Talano JAM, McArthur JA) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide 1 January 2019:1-417 3 Citations |
1 | 2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. (Murad MH, Liem RI, Lang ES, Akl EA, Meerpohl JJ, DeBaun MR, Tisdale JF, Brandow AM, Lanzkron SM, Chou ST, Webb S, Mustafa RA) Blood Adv 2019 Dec 10;3(23):3945-3950 15 Citations |
1 | American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. (Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA) Blood Adv 2020 Jan 28;4(2):327-355 224 Citations |
2 | American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. (Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E) Blood Adv 2020 Jun 23;4(12):2656-2701 148 Citations |
1 | COVID-19 disease in New York City pediatric hematology and oncology patients. (Gampel B, Troullioud Lucas AG, Broglie L, Gartrell-Corrado RD, Lee MT, Levine J, Orjuela-Grimm M, Satwani P, Glade-Bender J, Roberts SS) Pediatr Blood Cancer 2020 Sep;67(9):e28420 41 Citations |
1 | American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. (Sekeres MA, Guyatt G, Abel G, Alibhai S, Altman JK, Buckstein R, Choe H, Desai P, Erba H, Hourigan CS, LeBlanc TW, Litzow M, MacEachern J, Michaelis LC, Mukherjee S, O'Dwyer K, Rosko A, Stone R, Agarwal A, Colunga-Lozano LE, Chang Y, Hao Q, Brignardello-Petersen R) Blood Adv 2020 Aug 11;4(15):3528-3549 103 Citations |
1 | In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults". (Reddy P, Davies S, Majhail N, Sandmaier B, Hari P, Cutler C) Blood Adv 2020 Nov 10;4(21):5431-5432 1 Citation |
1 | Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. (Durani U, Major A, Velazquez AI, May J, Nelson M, Zheng Z, Hall AG, Alam ST, Reynolds R, Thompson JC, Kumbamu A, Das DG, Murphy MC, Henry E, Lee AI, Marshall AL, Wun T, Weeks LD) JCO Oncol Pract 2022 Apr;18(4):e586-e599 6 Citations |
2 | Utilization and optimization of an electronic self-administered bleeding assessment tool (E-Self BAT) for the screening of pediatric bleeding disorders in the hematology clinic. (Sharma R, Flood V, Jobe S, Punzalan R, Simpson P, Conway C, Malec L) Haemophilia 2023 Mar;29(2):685-688 |
1 | American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. (Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, Coppens M, Houghton D, James AH, Lang E, Moll S, Myers T, Bhatt M, Chai-Adisaksopha C, Colunga-Lozano LE, Karam SG, Zhang Y, Wiercioch W, Schünemann HJ, Iorio A) Blood Adv 2023 Nov 28;7(22):7101-7138 12 Citations |
2 | Implementation of a Bleeding Risk Screening Tool and Hematology Referral Process Prior to Pediatric Endoscopy. (McSorley B, Chugh A, Abazi T, Lerner D, Jobe S, Pan AY, Zhang L, Sharma R, Ashai-Khan F) J Pediatr Gastroenterol Nutr 2023 Nov 01;77(5):661-665 |
3 | Endpoint selection and evaluation in hematology studies. (Brazauskas R, Eapen M, Wang T) Best Pract Res Clin Haematol 2023 Sep;36(3):101479 |
2 | Endpoint selection and evaluation in hematology studies (Brazauskas R, Eapen M, Wang T) Best Practice and Research: Clinical Haematology September 2023;36(3) |
2 | Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479] (Best Practice & Research Clinical Haematology (2023) 36(3), (S1521692623000403), (10.1016/j.beha.2023.101479)) (Brazauskas R, Eapen M, Wang T) Best Practice and Research: Clinical Haematology March 2024;37(1) |